ID

34418

Descrição

Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01612286

Link

https://clinicaltrials.gov/show/NCT01612286

Palavras-chave

  1. 17/01/2019 17/01/2019 -
  2. 27/03/2020 27/03/2020 - Sarah Riepenhausen
Titular dos direitos

GSK group of companies

Transferido a

17 de janeiro de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Nasopharyngeal Carcinoma NCT01612286

Eligibility Nasopharyngeal Carcinoma NCT01612286

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosed metastatic npc patient who have received radiotherapy or chemoradiotherapy with an at least 6 months interval
Descrição

ID.1

Tipo de dados

boolean

have measurable lesions
Descrição

ID.2

Tipo de dados

boolean

no dysfunction of the major organs
Descrição

ID.3

Tipo de dados

boolean

can understand this study and give a signed informed consent certificates
Descrição

ID.4

Tipo de dados

boolean

without a history of allergic reaction to the biological agents
Descrição

ID.5

Tipo de dados

boolean

Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or lactating women; women of child-bearing age without contraception
Descrição

ID.6

Tipo de dados

boolean

with a serious infection or dysfunction of the major organs
Descrição

ID.7

Tipo de dados

boolean

have taken other antitumor drugs during the period of 30 days ahead of this clinical trial
Descrição

ID.8

Tipo de dados

boolean

allergic to the escherichia coli preparations
Descrição

ID.9

Tipo de dados

boolean

cann't understand this study and give a signed informed consent certificates
Descrição

ID.10

Tipo de dados

boolean

Similar models

Eligibility Nasopharyngeal Carcinoma NCT01612286

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
diagnosed metastatic npc patient who have received radiotherapy or chemoradiotherapy with an at least 6 months interval
boolean
ID.2
Item
have measurable lesions
boolean
ID.3
Item
no dysfunction of the major organs
boolean
ID.4
Item
can understand this study and give a signed informed consent certificates
boolean
ID.5
Item
without a history of allergic reaction to the biological agents
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
pregnant or lactating women; women of child-bearing age without contraception
boolean
ID.7
Item
with a serious infection or dysfunction of the major organs
boolean
ID.8
Item
have taken other antitumor drugs during the period of 30 days ahead of this clinical trial
boolean
ID.9
Item
allergic to the escherichia coli preparations
boolean
ID.10
Item
cann't understand this study and give a signed informed consent certificates
boolean

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial